Trials / Completed
CompletedNCT04788108
Oral Progesterone for Prevention of Miscarriage in Threatened Abortion
Oral Progesterone for Prevention of Miscarriage in Threatened Abortion: a Randomized, Double-blinded, Placebo-controlled Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Chulalongkorn University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This study evaluates the effectiveness of oral dydrogesterone in preventing miscarriage in threatened abortion. Half of participants will receive oral dydrogesterone, while the other half will receive oral placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dydrogesterone | Dydrogesterone tablet |
| DRUG | Placebo | Placebo tablet |
Timeline
- Start date
- 2021-08-01
- Primary completion
- 2022-08-31
- Completion
- 2022-08-31
- First posted
- 2021-03-09
- Last updated
- 2023-08-30
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT04788108. Inclusion in this directory is not an endorsement.